injection

2022 to include coverage of the AXA Portfolio at 31 October 2022. The AXA IGR is at 75% and a capital injection of €50m has been completed. The ownership structure of MAB and MIES are set out in the chart below. Bridge Strategic Holdings Limited... reporting period from €312,9m to € 372,1m. This increase was principally due to the acquisition of the AXA portfolio in October 2022 where a capital injection of €50m was carried out. The SCR increased from € 127,4m to € 147,7m over the reporting period

reporting period from € 14.0m to € 313m. This increase was principally due to the following 3 actions done over the year 2021: ▪ following the acquisition of the Allianz portfolio in April 2021, a capital injection of € 45m was carried out; ▪ following the acquisition of the Integrale portfolio in December 2021, a second capital injection of € 225m was carried out; ▪ for the acquisition of the Integrale book, MAB received more assets than liabilities, generating additional available own funds

execution of its strategy, the Company completed the acquisition of a new corporate business portfolio in 2024-2025, i.e. the Contassur Portfolio. Given the relatively limited size of the portfolio, there was no additional capital injection required to

December 2024 Page 19 of 93 Monument Group: PUBLIC injection required to take over the closed book of traditional life business. This transaction was successfully completed on 1 July. In line with the growth of the Company, the Company continues to

capital injection required to take over the closed book of traditional life business. Moreover, the Company entered into an agreement with a Belgian Insurance company for a life corporate insurance book transaction. This transaction is envisaged to